peripheral artery disease with cardiovascular disease
Cardiovascular · 2020–2020
1decision
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| rivaroxaban Prevention of recurrent cardiovascular events in patients at high risk of recurrent thrombotic events, specifically patients with peripheral artery disease… | Mar 2020 | Deferred | input received Diabetes Australia |
Who spoke
Diabetes Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.